Acute intermittent porphyria presenting with rhabdomyolysis and polyneuropathy with severe quadriparesis and respiratory failure: A case report.

Luka Bielen, Ana Vujaklija Brajković, Ozrenka Zlopaša, Nediljko Šućur, Mila Lovrić, Anja Šitum, Penelope Stein
{"title":"Acute intermittent porphyria presenting with rhabdomyolysis and polyneuropathy with severe quadriparesis and respiratory failure: A case report.","authors":"Luka Bielen, Ana Vujaklija Brajković, Ozrenka Zlopaša, Nediljko Šućur, Mila Lovrić, Anja Šitum, Penelope Stein","doi":"10.5492/wjccm.120909","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute intermittent porphyria (AIP) is the most common form of acute porphyria, a group of rare inherited disorders of heme biosynthesis. Severe attacks may be associated with life-threatening complications, including peripheral motor neuropathy, encephalopathy and seizures. Very rarely, an acute AIP attack can be complicated by rhabdomyolysis as illustrated in this case report.</p><p><strong>Case summary: </strong>A 28-year-old female presented with severe abdominal pain and muscle weakness, which progressed to severe rhabdomyolysis and acute kidney injury requiring dialysis. The disease course was further complicated by an acute severe axonal peripheral motor neuropathy with quadriparesis and respiratory muscle weakness requiring prolonged invasive mechanical ventilation. An important clue for diagnosis was red urine without hematuria. The diagnosis was established by the finding of elevated δ-aminolevulinic acid and porphobilinogen in a random urine sample and later confirmed by genetic testing. The patient was initially treated with hemin and parenteral glucose. However, since she needed prolonged treatment, givosiran was commenced and continued after discharge. When the period between givosiran administrations was extended to two months, this led to a new (milder) attack. After 40 months of givosiran treatment and continued physical rehabilitation, the patient is ambulatory and without acute attacks.</p><p><strong>Conclusion: </strong>Our case illustrates that treatment with hemin and givosiran for longer than two years may be needed for neurological recovery after an AIP attack with severe motor polyneuropathy and multisystem involvement.</p>","PeriodicalId":66959,"journal":{"name":"世界危重病急救学杂志(英文版)","volume":"15 3","pages":"120909"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548153/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"世界危重病急救学杂志(英文版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5492/wjccm.120909","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute intermittent porphyria (AIP) is the most common form of acute porphyria, a group of rare inherited disorders of heme biosynthesis. Severe attacks may be associated with life-threatening complications, including peripheral motor neuropathy, encephalopathy and seizures. Very rarely, an acute AIP attack can be complicated by rhabdomyolysis as illustrated in this case report.

Case summary: A 28-year-old female presented with severe abdominal pain and muscle weakness, which progressed to severe rhabdomyolysis and acute kidney injury requiring dialysis. The disease course was further complicated by an acute severe axonal peripheral motor neuropathy with quadriparesis and respiratory muscle weakness requiring prolonged invasive mechanical ventilation. An important clue for diagnosis was red urine without hematuria. The diagnosis was established by the finding of elevated δ-aminolevulinic acid and porphobilinogen in a random urine sample and later confirmed by genetic testing. The patient was initially treated with hemin and parenteral glucose. However, since she needed prolonged treatment, givosiran was commenced and continued after discharge. When the period between givosiran administrations was extended to two months, this led to a new (milder) attack. After 40 months of givosiran treatment and continued physical rehabilitation, the patient is ambulatory and without acute attacks.

Conclusion: Our case illustrates that treatment with hemin and givosiran for longer than two years may be needed for neurological recovery after an AIP attack with severe motor polyneuropathy and multisystem involvement.

急性间歇性卟啉症表现为横纹肌溶解和多神经病变,严重四肢瘫和呼吸衰竭:1例报告。
背景:急性间歇性卟啉症(AIP)是最常见的急性卟啉症,是一组罕见的遗传性血红素生物合成疾病。严重的发作可能伴有危及生命的并发症,包括周围运动神经病变、脑病和癫痫发作。正如本病例报告所示,急性AIP发作很少合并横纹肌溶解。病例总结:一名28岁女性,表现为严重腹痛和肌肉无力,并发展为严重横纹肌溶解和急性肾损伤,需要透析。病程进一步复杂化急性严重轴突周围运动神经病变伴四肢瘫和呼吸肌无力需要长时间的有创机械通气。红尿无血尿是诊断的重要线索。该诊断是通过在随机尿液样本中发现δ-氨基乙酰丙酸和卟啉胆红素原升高而建立的,后来通过基因检测证实。患者最初接受血红素和静脉注射葡萄糖治疗。然而,由于她需要长期治疗,因此开始使用吉伏西兰并在出院后继续使用。当吉沃斯兰政府之间的间隔延长到两个月时,这导致了新的(较温和的)攻击。经过40个月的吉福西兰治疗和持续的身体康复,患者可以走动,没有急性发作。结论:我们的病例表明,在AIP发作并伴有严重的运动多发性神经病变和多系统受累后,可能需要使用血红素和吉福西兰治疗超过2年的神经恢复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
216
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书